Month: December 2023

Dec 28 2023

Uncategorized

ED Visits for Schizophrenia Spectrum Disorders Up After Pandemic Onset

by Clinical Editor

No Comments

The number of emergency department visits for schizophrenia spectrum disorders increased after the onset of the COVID-19 pandemic, according to a study published online Dec. 27 in JAMA Network Open.

Dec 28 2023

Uncategorized

Woman with schizophrenia missing in Augusta

by Clinical Editor

No Comments

Tomeka Nelson, 48 years old, was last seen Dec. 26 on the 3400 block of Wrightsboro Rd. getting into an unknown vehicle.

Dec 28 2023

Uncategorized

A New Drug Compound Shows Promise for Schizophrenia

by Clinical Editor

No Comments

In a study published Dec. 14 in the Lancet, researchers report on a promising new treatment for the psychiatric disorder that could give patients better options. KarXT, developed by biotech...

Dec 28 2023

Uncategorized

Growing Up With Cats Linked to Higher Schizophrenia Risk

by Clinical Editor

No Comments

Scientists found that childhood cat ownership is associated with developing schizophrenia—a risk possibly fueled by a parasite.

Dec 28 2023

Uncategorized

Could Being Around Cats In Childhood Have A Link To Schizophrenia? Here’s What A Study Found

by Clinical Editor

No Comments

Infection from the toxoplasma gondii parasite found in cat feces and undercooked red meat is understood to have links to many unusual things, including mental illnesses.

Dec 27 2023

Uncategorized

Fundraising for schizophrenia support programs – CTV News Calgary

by Clinical Editor

No Comments

Fundraising for schizophrenia support programs  CTV News Calgary

Dec 27 2023

Uncategorized

BMS Strengthens Schizophrenia, AD Portfolio with $14B Acquisition of Karuna Therapeutics – Inside Precision Medicine

by Clinical Editor

No Comments

BMS Strengthens Schizophrenia, AD Portfolio with $14B Acquisition of Karuna Therapeutics  Inside Precision Medicine

Dec 27 2023

Uncategorized

How a gene linked to schizophrenia may have helped humans evolve

by Clinical Editor

No Comments

According to recent research, the genetic risk factors associated with schizophrenia have been gradually disappearing from the modern human genome. This is because of natural selection, the process …

Dec 27 2023

Uncategorized

A New Drug Compound Shows Promise for Schizophrenia

by Clinical Editor

No Comments

In a study published Dec. 14 in the Lancet, researchers report on a promising new treatment for the psychiatric disorder that could give patients better options. KarXT, developed by biotech...

Dec 27 2023

Uncategorized

BMS wagers $14bn on Karuna’s schizophrenia drug

by Clinical Editor

No Comments

BMS’ move for Karuna comes a few weeks after AbbVie agreed an $8.7 billion deal to acquire Cerevel Therapeutics, another company developing a schizophrenia drug with a novel mechanism of...